Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 14CNS 13Sarcoma 11Genitourinary 11Head & Neck 6Gynecologic 5Gastrointestinal 5Breast 4Other hematologic neoplasm 1Other 1Lymphoid 1Dermatologic 1

Conditions

Obesity 1Neurotoxicity Syndromes 1Fatigue 1

Interventions

Radiotherapy 9naloxegol 7Metformin 7Surveys and Questionnaires 6Cisplatin 6Exenatide 4Vitamin D 3Sugars 3Fibroblast Growth Factor 7 3Water 2Therapeutics 2Testosterone 2Resistance Training 2Radiation 2Nutrition Assessment 2Methods 2Low-Level Light Therapy 2Injections 2Fentanyl 2Drug Therapy 2Dexamethasone 2Cryotherapy 2Calcium Dobesilate 2Anastrozole 2prucalopride 1peppermint oil 1penclomedine 1pegfilgrastim 1oxycodone-acetaminophen 1methylnaltrexone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Radiotherapy, Conformal × Other × Clear all
NCT00807768 2019-03-20

Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer

GOG Foundation

Phase 3 Unknown
601 enrolled 13 charts
Other

Fatigue, Obesity, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡